FILTER

Refine your search with the following facets to narrow down your results.

6 Current news of NiKem Research Srl

NiKem Research Srl and Dualsystems Biotech AG Announce a Strategic Alliance

11-Jan-2012 - Dualsystems Biotech and NiKem Research announced the formation of a strategic alliance to jointly offer their respective drug/target profiling and drug discovery services to their clients.The ever increasing complexity and expense of drug discovery requires an excellent understanding of molecular ...

drug discovery

NiKem Research and Chiesi Farmaceutici Extend Research Collaboration

08-Sep-2011 - Chiesi Farmaceutici and NiKem Research have announced details of their extended research collaboration within the respiratory therapeutic area. Since 2001 Chiesi and NiKem successfully collaborate on several pre-clinical research projects where NiKem provides design, synthesis, hit validation, ...

drug discovery medicinal chemistry research collaborations

NiKem Research Receives Authorization for Rodent Toxicology Studies

05-May-2010 - NiKem Research announces that it has received on March 29th 2010, from the Italian Ministry of Health (Decree N. 69/2010-B), the authorization to perform acute and sub-chronic toxicology studies (up to 28 days) in all rodent species for preliminary safety evaluation of novel chemical entities ...

plasma services toxicology

NiKem Research receives certification for GLP Bioanalysis

17-Sep-2009 - NiKem Research announced that it has received, from the Italian Ministry of Health, GLP certification of its bioanalysis facilities to further extend its drug discovery service capabilities. NiKem Research has provided for many years bioanalytical support both for its in vitro ADME(T) and in ...

Bioanalytics GLP certification services +1

Servier and NiKem Research Srl Enter into a Discovery Research Service Agreement

17-Oct-2007 - Servier and NiKem Research Srl announced the signature of a Discovery Research Service Agreement. Under the terms of the agreement NiKem will, in the next 12 months, use its medicinal chemistry experience, and its iterative and parallel chemistry platform, to design and synthesize drug-like ...

chemistry kinase inhibitors medicinal chemistry

NiKem Research Srl Enters Into Research Service Agreement with InterMune, Inc.

26-Jun-2007 - NiKem Research Srl, an Italian drug discovery service provider, announced that it has entered into a Research Service Agreement with InterMune, Inc. Under the terms of the agreement, NiKem will, in the next 12 months, use its medicinal chemistry and early ADMET/PK platform and expertise to ...

medicinal chemistry pulmonology